ARCELLX

Serial Number 97208593
Registration 7300306
700

Registration Progress

Application Filed
Jan 7, 2022
Under Examination
May 2, 2023
Approved for Publication
Mar 7, 2023
Published for Opposition
Mar 7, 2023
Registered
Feb 6, 2024

Trademark Image

ARCELLX

Basic Information

Serial Number
97208593
Registration Number
7300306
Filing Date
January 7, 2022
Registration Date
February 6, 2024
Published for Opposition
March 7, 2023
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Feb 6, 2024
Registration
Registered
Classes
005

Rights Holder

Arcellx, Inc.

03
Address
800 Bridge Pkwy
Redwood City, CA 94065

Ownership History

Arcellx, Inc.

Original Applicant
03
Gaithersburg, MD

Arcellx, Inc.

Owner at Publication
03
Gaithersburg, MD

Arcellx, Inc.

Original Registrant
03
Redwood City, CA

Legal Representation

Attorney
Aaron D. Hendelman

USPTO Deadlines

Next Deadline
1644 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-02-06)
Due Date
February 06, 2030
Grace Period Ends
August 06, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

36 events
Date Code Type Description Documents
Feb 13, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Feb 13, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Feb 13, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Feb 13, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Feb 13, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Feb 6, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Feb 6, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 4, 2024 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Jan 3, 2024 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Dec 7, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 7, 2023 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Nov 7, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Oct 27, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 25, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
Oct 25, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 25, 2023 IUAF S USE AMENDMENT FILED Loading...
Oct 25, 2023 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Oct 25, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 7, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jul 7, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jul 7, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
May 2, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 7, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 7, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 15, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 27, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 16, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 15, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 15, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 13, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 13, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Sep 13, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 7, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 15, 2022 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Jan 14, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 11, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Biological preparations for the treatment of cancer using genetically engineered cells; pharmaceutical preparations for targeting tissues based on select tissue markers and ligands for treating cancer; pharmaceutical preparations for the purpose of binding ligands using receptors for treating cancer; pharmaceutical preparations for immunotherapy using genetically engineered cells for treating cancer
First Use Anywhere: 20200200
First Use in Commerce: 20200500

Additional Information

Design Mark
The mark consists of "ARCELLX" in navy blue in stylized form. To the left are two overlapping bars, one in purple and the other in a blue gradient that transitions to purple.
Color Claim
The color(s) navy blue, purple, and blue is/are claimed as a feature of the mark.

Classification

International Classes
005